Sentences with phrase «pharmaceuticals as research scientist»

After receiving his Ph.D., he joined Memory Pharmaceuticals as Research Scientist.

Not exact matches

Across the broad range of life science research under way in biotechnology and pharmaceuticals, many companies need scientists with traditional skills, such as pharmacology or biology.

So, I took a job as a research scientist in the analytical lab of a smaller chemistry - driven, discovery - based pharmaceutical company located in Vancouver, B.C. With fewer than 100 employees and no products on the market, it couldn't have been further from the formal corporate work environment I was accustomed to at a multinational company.

As such, opportunities for veterinary medical scientists run the gamut from biomedical and pharmaceutical research to public health and academia.

Besides helping scientists better gauge how precipitation ultimately soaks into sandy soils, the research could help them better understand industrial processes, such as pharmaceutical manufacture, in which liquids are sprayed onto dry powdered materials — possibly improving quality control and consistency in the final products.

«With the headcount constraints in today's economic climate, industry needs to hire leaders as well as technically excellent scientists,» says Scott Reines, newly retired vice president of pharmaceutical research and development at Johnson & Johnson, a pharmaceutical company based in New Brunswick, New Jersey.

Scientists have to be able to hit the ground running, as innovation in the pharmaceutical and biotechnology industries is a long and costly process, involving several stages of basic, applied, and clinical research, and often taking up to 15 years to complete.

Now, Wyss Institute researchers led by Church have developed a new suite of such sensors, reported in Nucleic Acids Research journal, that not only increase the number of cellular «switches and levers» that scientists can use for complex genetic re-programming, but also respond to valuable products such as renewable plastics or costly pharmaceuticals and give microbes a voice to report on their own efficiency in making these products.

These include government or private nonprofit funders of basic research, such as the National Institutes of Health in the United States or the Wellcome Trust in the United Kingdom; academic scientists; multinational pharmaceutical firms and smaller biotech companies; and, at the end of the line, government regulatory agencies responsible for drug approval.

«The development of this microfluidic lung model, as well as other organs - on - chip, holds the promise of improving the physiological relevance of cellular models for more accurate prediction of the effects of toxicants and drugs on humans, and for reducing the use of animals in medical and pharmaceutical research,» said Sonia Grego, Ph.D., research scientist at RTI and the project's principal investigator.

I moved to Vancouver, BC, Canada to join the biophysical characterization department of Celator Pharmaceuticals (a spin - off company from the BC Cancer Agency) as a research scientist before my next position took me to York, England.

He has also served as Director for Cancer Immunology and Immunotherapy for the Donald Monk Cancer Research Foundation; he is a partner at Veterinary Research Associates, LLC, a company focused on development and implementation of diagnostics for veterinary medicine and a founder / scientist at ApopLogic Pharmaceuticals, Inc, a biotechnology company focused on development of cancer therapeutics.